





1st Session, 36th Parliament,
46 Elizabeth II, 1997










The House of Commons of Canada










BILL C-239









An Act to amend the Consumer Packaging and 
Labelling Act (recombinant hormones)







R.S., c. C-38; 
R.S., cc. 27, 
31 (1st 
Supp.); 1992, 
c. 1; 1995,
c. 1; 1997, c. 
6


Her Majesty, by and with the advice and 
consent of the Senate and House of Commons 
of Canada, enacts as follows:









1. The Consumer Packaging and 
Labelling Act is amended by adding the 
following after section 4:







Labelling for 
prepackaged 
products


4.1 No prepackaged food product shall be 
sold that contains an ingredient derived from 
an animal to which a prescribed recombinant 
hormone has been administered unless that 
product has applied to it a label containing a 
declaration in the prescribed form










(a) stating that the prepackaged product 
contains an ingredient derived from an 
animal to which a prescribed recombinant 
hormone has been administered; and









(b) identifying the prescribed recombinant 
hormone.  









2. Subsection 18(1) of the Act is amended 
by adding the following after paragraph 
(e):










(e.1) defining ``prescribed recombinant 
hormone'';









(e.2) prescribing the form and manner of the 
declaration referred to in section 4.1.  







